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 “MANAGEMENT OF ESOPHAGEAL TUBERCULOSIS: A SINGLE 
CENTER EXPERIENCE” 
 
   INTRODUCTION 
                              Even in countries with a high incidence of 
tuberculosis, esophageal tuberculosis is a rare diagnosis. Esophageal 
tuberculosis is considered primary when there is no other detectable 
tuberculous site and secondary when the esophagus is involved by spread 
from adjacent organs or by hematogenous spread from a distant site. 
 
The natural history, clinical and endoscopic features, complications, and 
treatment of this condition is often unclear. 
 
We  present our experience with Esophageal tuberculosis 
encountered From Nov 2011 to March 2014 and highlight the tendency of 
esophageal   tuberculosis  to form an ulcerovegetative lesion thereby 
mimicking a neoplastic process. All the patients who were diagnosed and 
treated for  esophageal tuberculosis who were on follow up in our study 
period were also included. 
 
 
 
 
AIM OF THE STUDY 
                                   
           To study the demography, clinical features, endoscopic findings, 
radiographic abnormalities and outcome of antituberculous treatment with or 
with-out surgery for tuberculosis of the esophagus. To analyze the role of 
surgical therapy in managing this disease 
 
METHODS 
 
In our analyses, tuberculosis presenting with dysphagia can be broadly categorized 
into an ulcer group (UG, n=21) and an extrinsic compression group (n=10). The 
ulcerative form of ET which is often misdiagnosed as malignancy is reviewed. 
History and physical findings were noted. Chest radiographs, Upper GI endoscopy 
(including biopsies of esophageal lesions), biopsies or FNA cytology of lymph 
nodes, bronchoscopy, contrast esophagogram, and thoracic CT were performed.  
 
Diagnosis was made with histological proof of epithelioid cell granulomas with 
marginally polygonal Langhans-type giant cells and/or the presence of acid-fast 
bacilli. 
  
 
OBSERVATION: 
                                       SPECTRUM OF PRESENTATION 
 
 
Presentation No of patients 
TEF 7 
TEF following Mediastinal drainage 1 
Only Ulcer 5 
Ulcer with military TB 1 
Ulcer with contained perforation 1 
Ulcer with esophago cervical fistula 1 
Ulcer with cervical node 4 
Ulcer with sub carinal node 1 
 
 
 
 
  
 
CONCLUSION: 
                      This study shows that esophageal involvement is  not isolated in 
most patients. Dysphagia due to tuberculosis can be due to ulcerative lesions or 
extraluminal compression due to lymphadenopathy. 
 
It is not uncommon to find esophageal tuberculosis misdiagnosed as malignancy 
during endoscopy. 
 
Tuberculous involvement was confirmed by pathological examination in all 
patients. 
 
Although antituberculous therapy is the mainstay of treatment, surgery is reserved  
for complications and  persistent fistula despite adequate therapy. 
 
 
 
  Introduction
1INTRODUCTION
Even in countries with a high incidence of tuberculosis, esophageal
tuberculosis is a rare diagnosis.  Esophageal tuberculosis is considered
primary when there is no other   detectable tuberculous site and secondary
when  the  esophagus  is    involved  by  spread  from  adjacent  organs  or  by
hematogenous spread  from a distant site.
The natural history, clinical and endoscopic features, complications,
and treatment of this condition is often  unclear.
We present our experience with Esophageal tuberculosis
encountered  From Nov 2011 to March 2014 and  highlight the tendency of
esophageal   tuberculosis   to form an ulcerovegetative lesion  thereby
mimicking a neoplastic process. All the patients who were diagnosed and
treated for  esophageal tuberculosis who were on follow up in our study
period were also included.
Esophageal Tuberculosis disease is  complex and mandates critical
preoperative evaluation for optimal management. We ventured to collect
the data of all these patients and analyze them in detail for better
understanding of this uncommon disease.
Aim
2AIM OF THE STUDY
To study the demography, clinical features, endoscopic findings,
radiographic abnormalities and outcome of antituberculous treatment with
or with-out surgery for tuberculosis of the esophagus. To analyze the role
of surgical therapy in managing this disease.
Review of Literature
3REVIEW OF LITERATURE
The esophagus is double –layered  structure lined by mucosa that
passes  through   the  neck,  chest,  and  abdomen .It  starts  at  the  base  of  the
pharynx at C6 and ends in the abdomen, where it joins  the cardia of the
stomach  at  T11.   It  is  about   25-  to  30-cm and  it  finds   its  way   through
most  vital structures in the mediastinum.
It descends in the mediastinum close to the left main stem bronchus
and it  gets deviated to left and enters the diaphragm through the
esophageal  hiatus at the level of the 11th thoracic vertebra. The narrowest
point of the  gastrointestinal tract is  at the level of the cricopharyngeus
muscle.It is the  starting point of the esophagus. At the level of the carina,
left  mainstem bronchus  and  Aorta  goes  very  close  to  esophagus  & at  the
level of the fourth thoracic vertebra esophagus gets narrowed because of
bronchoaortic  constriction  which   measures  15  to  17  mm.  At  the  end  of
esophagus is the diaphragmatic constriction, measuring 16 to 19 mm.
 Esophagus have numerous interconnecting lymphatic plexuses
arising  from the sub mucosa and muscularis layers.
4ARTERIAL SUPPLY
There are three principal arterial supply for esophagus. In the neck
,superior and the inferior  thyroid arteries  supply the cervical esophagus.
TracheobronchIal arteries arise from arch of the aorta and supply the
thoracic esophagus. Small proper esophageal arteries arise directly from
the  thoracic aorta and supply the thoracic esophagus. Lower part of
esophagus is supplied by branches from left gastric arteries .About 11
branches arise from the left gastric arteries and supply the lower part of
esophagus. Liebermann-Meffert said that all these arteries when they come
near the esophagus they form  minute branches  and then enter the
esophagus to supply the esophagus . After entering the esophageal wall
they give vascular supply to the muscularis propria and then form a
submucosal and mucosal vascular plexus.This helps surgeon to do
Transhiatal esophagectomy safely with very minimal blood loss .
5
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7VENOUS SUPPLY
Venous supply of the esophagus can be divided  into intrapairetal
veins and plexus and extraparietal veins. Intrapairetal  veins are
intraesophageal and extra esophageal veins. Intra esophageal veins are the
sub epithelial veins in the lamina propria of the mucosa and these veins
cross the muscular layer and in the periesophageal area  to  form a plexus
of extraesophageal wall veins .No valves are present in  the esophageal
venous circulatory system. Extrinsic veins drain into the locally
corresponding large vessels: the inferior and superior thyroid veins, the
azygos and hemiazygos veins, and the gastric and splenic veins.
LYMPHATIC DRAINAGE OF ESOPHAGUS
 Lymphatic  of  esophagus  first  starts  in  the    submucosal  level  and
then penetrate muscularis propria and drain into the plexus in the
esophageal wall in the longitudinal direction, from here they egress and
drain into the regional lymph nodes. Lymph capillaries start in the mucosa
and then unite to form blind endothelial sacculations or channels.
Lymphatics originate in-between mucosa and sub mucosa and they form
collecting channels within the sub mucosa. These collecting channels run
parallel to the organ axis. Lymph flows in cranial direction into the
thoracic duct or subclavian lymph trunks from above the carina whereas
8lymph  flows mainly toward the cisterna chyli via the lower mediastinal,
left gastric, and celiac lymph nodes from below the carina. Esophageal
venous plexus don’t have valves but the lymphatic channels in the
esophagus have valves.
.
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TUBERCULOSIS OF THE ESOPHAGUS
Tuberculosis infection is caused by Mycobacterium tuberculosis
complex .Transmission is through air borne spread of droplet nuclei from
infected patients .Organism belongs to the family of Mycobacteriaceae and
of Actinomycetales order .Among the pathogenic species ,human disease
causing agent is  Mycobacterium Tuberculosis .This non spore forming
aerobic bacterium is neutral on gram’s staining, classified as ACID FAST
BACILLI because they cannot be decolorized by acid alcohol following
gram’s staining .This is due to the high content of  mycolic acids ,long
chained cross linked fatty acids and cell wall lipids . More than 90 % of
cases are reported from developing countries. Most potent risk factor is
HIV coinfection which tend to suppress cellular immunity. Following the
acquisition of specific immunity and accumulation of numerous activated
macrophages at the primary site (tubercles) granuloma are formed.
Gastrointestinal tuberculosis accounts  to  only 3.5 % of extra pulmonary
cases .Various routes of pathogenic spread are swallowing of sputum
(direct ) , hematogenous spread, consuming of milk from cows affected by
bovine tuberculosis .Prevalent sites in GIT are terminal ileum and caecum.
Tuberculosis is systemic disease. Though it affects lungs most often
it can affect other organs including esophagus. When it affects esophagus
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it can be primary esophageal tuberculosis or it can affect esophagus
secondary to pulmonary or miliary tuberculosis or secondary to cervical or
mediastinal nodal disease because of tuberculosis .Esophageal tuberculosis
consists of 0.3 % of gastrointestinal tuberculosis.1
Mycobacterium tuberculosis gains entry into the body through
respiratory tract and can spread by hematogenous or lymphatics.
The Esophagus is a dynamic organ with coordinated peristalsis.
When patients with pulmonary tuberculosis swallows infected sputum the
exposure of the esophagus to tuberculous organism is limited because of
easy clearance of tuberculous organism down to the stomach due to
coordinated peristalsis along with good functioning lower esophageal
sphincter and upright posture 2.  This  is  why  esophageal  tuberculosis  is  a
rare entity. Clinical presentations are dysphagia, pain in retrosternal area,
fever, weight loss, and cough with expectoration.3, 4 The symptom which
occurs most frequently in esophageal tuberculosis is dysphagia 3,4.
 Infection spread to the esophagus by various mechanisms. It can be
due to
1. Swallowed tuberculous sputum
2. Spread from pharyngeal or laryngeal lesion.
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3. Spread from mediastinitis ,hilar lymph nodes,  vertebrae3 or
lymphatic spread in retrograde manner 5.
4. In miliary tuberculosis by hematogenous spread 5.
Esophageal tuberculosis can have various presentations like ulcer in
the esophagus or stricture or even tracheo esophageal fistulae 6.
Esophageal tuberculosis affects the mid esophagus commonly
because of its contact with mediastinal lymph nodes near the carina 7. In
majority of patients with hilar and mediastinal lymph nodes, tuberculosis
affects the esophagus by direct extension 8.Therefore the upper and middle
third of esophagus is most commonly involved.
Mediastinal tuberculosis affecting adults is rare and presenting as
dysphagia is even more uncommon. The usual presentation is an ulcer in
esophagus, mucosal or sub mucosal mass with ulceration, fistula or sinus
formation, extrinsic compression, or displacement of esophagus 9, 10, 11, 12,13.
Esophageal tuberculosis can be divided into three distinct
histomorphological types.
1. Most common is the ulcerative type:
The sub mucosa of the esophagus gets infected by mycobacteria,
initially leading to tubercle formation. This tubercle progresses to nodule
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formation followed by caseous necrosis leading to ulceration. This ulcer
involves only the mucosa and sub mucosa and appears as an ulcer with a
purulent base. The edges are irregular and usually superficial. This ulcer
can penetrate deeper and produce complications like esophageal
perforation, esophageal mediastinal/ cervical fistula or sinus,
Esophagopleural fistula or even aorta esophageal fistula. Aortoesophageal
fistula presents with massive hemorrhage and death .Esophageal sub
mucosal ulcer has a capacity to heal by itself. The healing by fibrosis leads
to a scar and in turn can produce an esophageal stricture.
2.  Hyperplastic type
In esophageal tuberculosis, tuberculous granulation tissue formation
is more profound along with fibrous tissue hyperplasia. Sometimes this
massive hyperplasia can produce a tumor like mass giving a pseudotumour
appearance resulting in luminal narrowing.
3. Granular esophageal tuberculosis is the least common type.
Esophageal tuberculosis can be diagnosed by various imaging
modalities like chest radiograph, barium esophagogram, upper GI
endoscopy, bronchoscopy, CECT chest /neck, MRI chest and Endoscopic
ultrasound.
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With the help of image guided biopsy or direct biopsy, diagnosis is
confirmed by histopathological examination, identification of Acid fast
bacilli, culturing of biopsy material or Polymerase chain reaction analysis
of the sample specimens.
ENDOSCOPY IN ESOPHAGEAL TUBERCULOSIS
In the reported literature, the findings on endoscopy include a
variety of lesions like midesophageal ulcer, sub mucosal tumor,
midesophageal mass, sessile polyp with irregular surface, long narrow
strictures due to mediastinal fibrosis, esophageal stenosis, traction
diverticulum, sinus, and fistulous tracts to bronchus. Ulcerative lesion,
typically have a shallow, smooth edges, granular appearance, with small
mucosal miliary granulomas 14.
Plain chest radiograph
Chest radiograph was abnormal in 65% of people in one study.
Although in most patients chest radiograph are inconclusive, characteristic
lesions in lungs or spine suggestive of tuberculosis can be identified.
Other findings on a Chest radiograph include Para tracheal or
mediastinal mass lesion, pleural effusion and old fibrosing pulmonary
lesion.
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CONTRAST ESOPHAGOGRAM
Esophageal tuberculosis usually affects the middle third of the
esophagus. Barium esophagogram usually shows an external compression
due to mass lesion in the mediastinum due to lymphadenopathy. Other
findings which can be noted are mediastinal sinus, strictures, fistulous
tract, kinking, pseudotumor mass, traction diverticulum, polypoid lesion,
ulcers, and irregularity of mucosa.
Barium esophagogram usually performed in patients suspected to
have tracheo-esophageal fistula. It shows filling of barium in the
tracheobronchial tree. In cases where barium is aspirated into the
respiratory tract, it will be seen filling the larynx and the entire
tracheobronchial tree, a finding which helps in differentiation from
Tracheo esophageal fistula (TEF). Of particular importance, it should be
emphasized that gastrografin or high osmolar oral contrast agents should
not be used in suspicious cases of TEF. If these agents are aspirated in the
respiratory tract, they result in pulmonary congestion and necrotizing
pneumonitis which may be life threatening.
ENDOSCOPIC ULTRASOUND (EUS)
 EUS and EUS guided Fine-needle aspiration (FNA) is a good
modality for evaluating the esophageal wall and adjacent mediastinal
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lymph nodes. Mediastinal lymph nodes affected by tuberculosis appear
matted, conglomerate and heterogeneous with hypo echoic center with
intervening hyper echoic strands and foci. Mediastinal & Subcarinal region
was the most common site of lymphadenopathy in esophageal
tuberculosis. Esophageal endoscopic ultrasound can aid in the diagnosis
and response to treatment. 15
CONTRAST ENHANCED COMPUTERISED TOMOGRAPHY
(CECT ) OF THE CHEST AND NECK
Esophageal tuberculosis may show thickening of the mid esophagus
with enlarged mediastinal lymph nodes in the subcarinal region and
evidence of pleural effusion. Periesophageal lymph nodes and pulmonary
lesions can be demonstrated on CT.
Mediastinal air and contrast leak can be appreciated in CT thorax
suggestive of esophageal perforation or esophgomediastinal sinus.
Tuberculous mediastinal lymphadenopathy shows characteristic hypo-
dense center on CECT
CECT can demonstrate TEF. The present day multislice CT with 3D
reconstruction can provide us with exquisite images of the fistula and its
relation to surrounding structures, thereby aids in planning surgical
treatment or stent deployment.
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BRONCHOSCOPY
Tuberculous subcarinal lymph nodes enlargement produces tracheal
splaying.  The presence of mucosal and sub mucosal grey-white nodules in
the trachea may suggest the granular form of esophageal tuberculosis.
Ulcerative lesions are also identified in bronchoscopy. Even a small
tracheoesophageal fistula or tracheobronchial fistula can be identified in
bronchoscopy with the application of methylene dye into the esophagus;
the dye can be demonstrated coming through the fistulous opening in the
trachea or bronchi.6
TISSUE BIOPSY
Tissue biopsy to confirm tuberculosis is obtained by taking samples
from the ulcer seen in endoscopy or via bronchoscopy. It can also be
obtained by CT guided biopsy or taking biopsies directly from the nodal
mass or from the diseased wall of the esophagus during open drainage of
the mediastinum. In case of tuberculosis affecting the cervical esophagus
FNAC or cervical node biopsy is done for confirmation of tuberculous
etiology. EUS guided biopsy also helps to establish the diagnosis of
tuberculosis.
Histological proof of epitheloid cell granuloma with marginally
polygonal giant cells of langhans-type or the presence of acid fast bacilli
18
confirms the diagnosis.
AFB staining is done with ziehl neelsen staining.
Steps of the procedure
1. Carbol fuchsin Staining
2.  Steam heat for 7 minutes-
3. Water wash
4. Decoloraization with 20% H2SO4-
5. 95% ethanol wash
6.  Counterstained with loeffer`s methylene blue /1% picric acid /0.2 %
malachite green.
Tubercle bacilli appear as bright red rods seen under oil emersion
lens.
Only 35% of gastro intestinal tuberculosis shows positive in culture.
It usually takes 8 weeks to get the results .Culture media used to grow
tubercle bacteria is Lowenstein Jensen media.
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TREATMENT
Antituberculous drugs for gastrointestinal tuberculosis
recommended by WHO for
1. Uncomplicated Extrapulmonary case -4 drugs for 2 months and 2
drugs for 4 months.
2.  Complicated  Extrapulmonary  cases  -4  drugs  for  2  months  and  2
drugs for 7 months.
Many patients undergo one year treatment and this is advised to
overcome the recurrent tuberculosis and the complications encountered in
gastrointestinal tuberculosis.
First line drugs
 Rifampicin -10mg/kg,
Ethambutol-15mg/kg,
 Isoniazid -5mg/kg,
Pyrazinamide -25mg/kg.
Second line of drugs
Amikacin,
Kanamycin,
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Para amino salicylic acid,
Ciprofloxacin,
Ofloxacin,
Clarithromycin,
Azithromycin,
Rifabutin.
Patients with esophageal tuberculosis on medical therapy are
followed in regular intervals. Symptom improvement. (dysphagia
improvement), body weight gaining , improvement in appetite, and
absence of fever should be analyzed. Repeat endoscopy to appreciate the
reduction in size of the esophageal ulcer and improvement in luminal
narrowing.
Patients who are not responding to the medical treatment within 6
weeks should be reassessed to rule out drug resistance and associated
diseases like malignancy, crohns disease and eosinophilic esophagitis.
SURGICAL MANAGEMENT
Following are the surgical management options :
Drainage
           Cervical node suppuration-neck drainage.
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Thorocotomy and drainage- mediastinal    suppuration
Fistula repair – for tracheoesophageal fistula.
Surgical management is necessary by some patients who present
with mediastinal collection or mediastinal lymphadenopathy and pleural
effusion. In such conditions, open drainage is done by thoracotomy and
wall biopsy taken from the esophagus or from the nodal mass in the
mediastinum.
When the patient presents with suppurating neck abscess, it is
usually drained under general anesthesia through a cervical incision in a
nondependent site.
 Patients with tracheoesophageal fistula in the middle third of the
esophagus often require thoracotomy to repair the fistula. Right
thoracotomy is usually done in fourth intercostal space. Patient is
positioned in left lateral position and it is performed with single lung
ventilation. When the thorax is opened, extensive adhesions are present
which are carefully released to identify the fistulous tract. The esophageal
and tracheal ends are dissected  and the fistula is  hooked around with
umbilical tape. The fistulous tract is  then excised. Tracheal defect closed
with absorbable suture material like polyglactin  2-0 and the esophageal
end by 3-0 vicryl. The procedure can be complicated by leaks, collection,
sepsis, stricture or recurrent fistula formation.
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Studies have reported that if a vasculised  tissue is interposed
between the fistulous repair site then the chance of complication and
recurrence is less. Hence pedicled intercostal muscle flap or a pleural flap
can be used between the fistulous repair sites.
          . Camargo and colleagues have done study of Nonmalignant TEF
surgical treatment. They performed the repair without the use of muscle
interposition between the suture lines sixteen of his patients underwent
tracheal resection. Vascularized flap interposition was not done reasoning
that the risk of dysphagia and tracheal stenosis is avoided, caused by the
interposed muscle pushing the membranous tracheal wall or the esophagus.
Despite this study with impressive postoperative results, using vascularized
tissue to separate tracheal and esophageal suture lines are recommended by
many authors.
Patient who is presenting with mediastinal mass with suppuration of
mediastinal lymph nodes and collection in the mediastinum is drained by
thoracotomy and if necessary excision of nodal mass which produces
obstruction to the esophageal lumen. All the patients who undergo surgical
treatment are given antituberculous drugs for 6 months.
In some cases, Tracheal resection may be necessary to treat the
tracheoesophageal fistula. If resection is done ,it is reconstructed primarily
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with end to end anastomosis and postoperatively the neck is  immobilized.
If the fistula (TEF) is in the neck, after excision of the fistula the opening
in the esophagus and the trachea should be closed seperately with a viable
strap muscle or sternocleidomastoid muscle interposed in-between the two
suture lines.
All the patients who undergo surgical intervention for
tracheoesophageal fistula have bilateral chest drains and post-operative
incentive spirometry advised to reduce the incidence of respiratory
complications. If the patient develop complications like leak or abscess
collection it should be immediately drained.
Stenting for Airway-esophageal fistulas
Before the advent of endoscopic metallic stent insertion,
conventional esophageal prosthesis was used for stenting. Lux and Wilson
initially reported the placement of Wilson-Cook prosthesis and achieved
satisfactory results. However, these conventional prosthesis are known to
migrate distally especially in a dilated esophagus and also does not
prevent food spilling around the edges of the device and entering the
respiratory tree, in a so-called, ‘funnel phenomenon’.
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 Complications of stent placement include perforation when placed
in  the  cervical  regions  of  the  esophagus,  stridor  due  to  compression  of
major airways and stent migration. Incomplete closure of the fistula
caused by spillage of material through a gap between the proximal stent
margin and the esophageal wall can occur and result in persistence of
contamination of respiratory passage. This can be managed by glue
injection to seal the gap or by placement of additional stents.
Materials and Methods
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MATERIALS AND METHODS
All patients with verified esophageal tuberculosis during the study
period from November 2011 to March 2014 were included in the study.
Eleven patients with esophageal tuberculosis were studied in this period.
All the patients with confirmed esophageal tuberculosis since 1996 who
were on follow up (called through phone and letters) in our study period
were also included. Their previous case records were reviewed and the
latest follow up data was updated in the study.
The patients’ demographic data including Name, Age and Sex, were
documented. An accurate history taking and clinical examination was
done and recorded systematically. For review cases case records were well
maintained and were used for analysis in our study.
The investigative modalities undergone by the patient was noted.
Chest radiographs, Upper GI endoscopy (including biopsies of
esophageal lesions), bronchoscopy, contrast esophagogram, and CT thorax
and neck were performed. Some patients needed direct thoracotomy and
drainage and biopsy from the esophageal wall or from the nodes.
Diagnosis was made with histological proof of epithelioid cell
granulomas with marginally polygonal Langhans-type giant cells and/or
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the presence of acid-fast bacilli.  Ziehl Neelsen technique is used to look
for acid fast bacilli.
Tissues were taken by FNAC or biopsy from cervical nodes . CT
guided  biopsy is done to get the tissue from the mediastinal nodes,
Similarly Endoscopic ultra sound guided biopsy or direct thoracotomy and
biopsy was done to get the tissue from mediastinal nodes or from the
esophageal wall. Endoscopic and bronchoscopic tissue biopsy was done
for the lesion accessible through endoscopy or bronchoscope.
The etiology of the esophageal tuberculosis, and the treatment
offered to each patient was noted. The patient’s clinical course was closely
monitored and recorded during every follow up visit.
In our analyses, tuberculosis presenting with dysphagia can be
broadly categorized into an ulcer group (UG, n=21) and an extrinsic
compression group (n=10).
         Results
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RESULTS
DEMOGRAPHICS
The age distribution was between 20-70 yrs. There were 4 patients
(20-30 years ), 4 patients (30-40 years), 8 patients (40-50 years), 7 patients
(50-60 years) and 8 patients (60-70 years).  Most of the patients presented
between 40 -70 years of age.
Age distribution No of patients
0-10 0
10-20- 0
20-30 4
30-40 4
40-50 8
50-60 7
60-70 8
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Sex distribution
The Male to female ratio was 1.6:1 .
Male Female
19 12
29
Duration of symptoms ranged between 4 months to 19 months.
Symptoms ranged from dysphagia predominant (n=12) , dysphagia with
cough, weight loss  &fever(n=7),dysphagia with coarseness of  voice (n=1)
and odynophagia (n=3).
Clinical presentation No of patients
Dysphagia ( isolated) 22
Dysphagia with cough & wt. loss 7
Dysphagia with hoarseness 1
Dysphagia with odynophagia 1
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Co morbidities included, diabetes mellitus in 8 patients, obstructive
airway disease in 4 patients, one patient with history of  miliary
Tuberculosis and 3 patients with previous history of tuberculosis.
SPECTRUM OF PRESENTATION
Spectrum of presentation No of patients
Ulcer Group 21
Extra luminal Group 10
31
SPECTRUM OF PRESENTATION
FLOWCHART
Tuberculosis
Causing Dysphagia
n=31
Ulcer Group
N=21
Extraluminal
Group
n=10
Primary esophageal
ulcer
n=5
Secondary Esophageal
Tuberculosis
n=16
Tracheoesophageal
fistula
n=8
Mediastinal Node
n=8
Cervical node
n=2
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ULCER GROUP
Presentation No of patients
TEF 7
TEF following Mediastinal drainage 1
 Only Ulcer 5
Ulcer with military TB 1
Ulcer with contained perforation 1
Ulcer with esophago cervical fistula 1
Ulcer with cervical node 4
Ulcer with sub carinal node 1
33
Ulcer Group : Spectrum of presentation
Extra luminal group -10
Carinal /Sub-carinal node 8
Cervical node 2
Extraluminal group : Spectrum of Presentation
34
Endoscopic findings (FIG-10 a,10b,10c):
In the ulcerative group
1. Middle third esophageal ulcers seen in 7 patients.
2.  6 patients had ulcers in upper third esophagus.
3. Trachea-esophageal  fistulous openings in the esophagus was seen in
4 patients. However,  the fistulous ends were not identified in 3
patients due to esophageal folds or granulation tissue
In the extraluminal group :
1. Extrinsic compression in  the middle third of the esophagus seen in 6
patients.
2. Lower third  esophageal compression seen in 2 patients and
3. Upper third esophageal extrinsic compression in 2 patients.
               Findings Number of cases
Middle third esophageal ulcer 7
Upper third esophageal ulcer 6
TEF opening 4
Extrinsic compression in  the middle third 6
Lower third  esophageal compression 2
Upper third esophageal extrinsic compression 2
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RADIOLOGICAL FINDINGS
Radiography of chest (Fig-1) was abnormal in 11 patients
1. Two patients with tracheoesophageal fistula had  evidence of
Aspiration pneumonitis (one with bilateral infiltrates and other with
Right basal infiltrates).
2. One  patient with  previous history of  pulmonary tuberculosis had
bilateral lower lobe infiltrates suggestive of  pulmonary
Tuberculosis.
3. Loss of  paratracheal stipe was present in 5 patients and
4. Enlarged Soft tissue shadows suggestive of  neck nodes  in 3
Patients.
Barium esophagogram was done in 20 out of 31 patients in the
study group . (Fig 2,3&4)
In the Ulcerative group , the findings were:
1. 6 patients demonstrated fistula between esophagus and trachea.
2. 1 patient developed TEF after mediastinal drainage for nodal
suppuration
3.  one (1) patient showed mid esophageal ulceration and luminal
narrowing
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4. one patient showed narrowing in upper third of esophagus
5.  One patient showed normal study.
In Luminal compression group all the patient underwent barium
esophagogram
1.  Two patient showed luminal narrowing in upper third
esophagus.
2. Three patients showed extrinsic compression in middle third
of esophagus
3. Two patients showed extrinsic compression at subcarinal
level.
4.  Three patients showed a normal barium study.
CT Chest & Neck: (Fig5a, 5b, 6,7a,7b &8)
All patients underwent CECT Chest and Neck except 2 patients.
In the Ulcer Group
1. Fistula was appreciated in 4 patients out of 8 patients with
tracheoesophageal fistula .In the remaining patients CT showed only
narrowing and thickening of esophagus. TEF was diagnosed with
barium or during bronchoscopy.
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2. 4 patients showed lymphadenopathy of sizes from about 2cm to
5cm. mediastinal collection was seen in one patient.
3. 7 patients showed no abnormalities in CT scan.
4. In 2 patients CT demonstrated Esophageal narrowing in the upper
Third.
5. CT was not done in 2 patients.
In the extrinsic  compression group,
1. 6 patient showed mediastinal enlarged nodes and Evidence of
suppuration in 1 patient
2. 1 patients showed cervical lymphadenopathy
3. 3 patients showed no abnormalities in CT scan.
CECT findings No of Cases
Mediastinal Lymphadenopathy
± Suppuration
10
Cervical lymphadenopathy
+ suppuration
1
TEF 4
Esophageal Thickening 2
Esophageal stricture 2
Normal 10
Not Done 2
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Bronchoscopy: (Fig-11)
Bronchoscopy was done in 10 of our patients. It showed ulcer with
fistulous opening in 5 patients, ulcer alone in 2 patients, Carina lifting up
in 2 patients and normal 1 patients.
              Findings               number of cases
Ulcer with fistulous opening                     5
Ulcer alone                     2
Carina lifting  up                      2
Normal                      1
Endoscopic ultrasound (EUS) (fig 9 a &b)
It was done in only two patients. Mediastinal lymphadenitis with
esophageal wall thickening seen in the 2 patients and both of them
underwent EUS guided biopsy.
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CHEST X RAY
                                                      Fig 1
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BARIUM STUDIES
Fig -2
              Fig -3                                                             Fig 4
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ULCERATIVE LESION IN THE ESOPHAGUS - LUMINAL
NARROWING.
CERVICAL NODAL SUPPURATION
Fig 5a: Cervical Node Enlargement
FIG – 5b : CT OF NODAL SUPPURATION,
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FIG – 6 : MD CT OF NODAL SUPPURATION
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FIG 7 a: Reconstructed Image showing sinus Tracts
Fig-7b. Sinus tract with pleural effusion
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Fig 8: CT showing Subcarinal lymphadenopathy
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Endoscopic ultrasound
Fig 9 a
Fig 9 b
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ENDOSCOPY- ESOPHAGEAL TUBERCULOSIS
Fig 10
Fig 10a                             fig 10 b                                  fig 10c
a. ON DIAGNOSIS b.3 MONTHS AFTER
ATT
c.HEALED SCAR ON
COMPLETION OF
ATT
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BRONCHOSCOPY-ULCERATIVE LESION
Fig -11
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HISTOPATHOLOGY & CYTOLOGICAL FINDINGS
Esophageal tuberculosis was confirmed with histopathological
examination in 28 patients, and with FNAC in 4 patients.
Methods of
diagnosis No of cases
Granulomatous
Lesions
AFB positive at
Ziehl neelsen
CT biopsy 8 8
Bronchoscopy
biopsy
2 2
Endoscopic
biopsy
14 13 1
Cervical node
biopsy
2 1 1
EUS FNAC 2 0 2
Esophageal wall
biopsy
3 3
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TREATMENT
All the patients were treated with antituberculous treatment of
Isoniazid  Rifampicin ,Ethambutol and Pyrazinamide for 3 months
followed by Isoniazid and Pyrazinamide.for the next 6 months.
TRACHEOESOPHAGEAL FISTULA REPAIR
In the Ulcer group there were 8 patients with  tracheoesophageal
fistula (TEF). One patient presented with TEF following mediastinal
drainage for nodal suppuration  . Of  these,4 patients have undergone
surgical treatment.
OPERATIVE PROCEDURE
The surgical treatment involved trachea esophageal fistula excision
and repair via Trans thoracic approach. All the procedures were done
under General anesthesia, with single lung ventilation and  double  lumen
endotracheal tube. With the patient  in left lateral position postrolateral
thoracotomy was done through fourth  intercostal space. The adhesions
between lungs and the fistulous tract area were released. The esophagus
near the fistulous site was mobilized. The fistula was dissected and hooked
around with umbilical tape. Similarly the intrathroacic trachea was
dissected and the fistulous tract (fig 12) was separately hooked out with
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umbilical tape. The fistulous tract was excised and the tracheal defect was
closed with absorbable suture material (2-0 Vicryl ). The esophageal defect
was sutured with 3-0 Vicryl in two layers.(fig-13). A pedicled interposition
intercostal muscle flap was placed for 3 patients in between the repaired
ends. In one patient a pleural flap (fig -14) was interposed between the
suture lines. After repair air leak was checked in the tracheal side. And a
Ryle’s tube was passed across the repair for temporary feeding.
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Fig-12: Isolation of fistula
fig-13:Repair of fistula
fig 14:Pleural Interposition
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OPEN MEDIASTINAL DRAINAGE
Three patients had caseous mediastinal lymph nodes with abscess
formation inside the mediastinum .They were managed by open drainage
through a right thoracotomy. Chest drain was kept bilaterally. Post
operatively under cover of   antituberculous drugs the 3 patients recovered
completely.
CERVICAL DRAINAGE
One patient with large suppurated cervical adenopathy required open
drainage under anesthesia.
STENTING
In 3 patients temporary stenting of Tracheoesopheageal was done in
patients considered unfit for surgery, while being treated medically with
ATT. Stent placement was successful in all three patients. The Fistulas
remained sealed with no stent migration. The stents were removed after
ATT Completion and there were no residual lesions or fistula in all three
patients. The stents were easily removed after therapy (mean duration of 6
months after completing ATT).
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Mode of treatment No of patients
Transthoracic TEF  repair 5
Open Mediastinal Drainage 3
Cervical Drainage 2
Stent 3
Medical therapy alone 18
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OUTCOME
Patients were followed up for a median duration of  2 years (range 3
months to 6 years ). All patients had complete healing of the lesions except
in  1  patient  who  had  a  residual  diverticulum  .  Relief  of  Dysphagia  was
present in all patients and there was no mortality during the follow –up
period .
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Follow up OGD after 5 years
 Discussion
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DISCUSSION
Esophageal tuberculosis is a very rare disease and the incidence is
about 0.15 % of those who die of tuberculosis3. Even though primary
tuberculosis is rare we have reported 5 cases in our series (16.1%) without
any evidence of tuberculosis elsewhere.
Secondary form of Esophageal tuberculosis is due to extension of
the disease from adjacent organs or by hematogenous spread from a distant
site. 22  Secondary form of esophageal Tuberculosis was the most common
in our series with an incidence 83.9% (n=26).
In these patients , the mediastinal or Cervical Tuberculous
lymphadenopathy  mass may compress the esophagus and produce
dysphagia.( n=10, 33.8%) 6
When these nodes suppurate , the  abscess can rupture into  the
esophagus to produce ulceration or  sinus formation. This disease process
may lead to a fistula when the trachea is also involved. Esophageal
tuberculosis  producing Tracheaoesopheal fistula was present in 8 patients
(25.8%)
Esophageal tuberculosis most commonly presented with dysphagia
(n=31, 100%). In addition, few patients presented with fever (n=11,
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35.5%) and weight loss (n=11, 35.5%) . The patients who have cough with
aspiration were diagnosed with tracheoesophageal fistula.(n=8,25.8%) 5 .
Endoscopy may show ulceroproliferative growth mimicking a
neoplastic process . When biopsy from these lesion shows  chronic
inflammation and caseating or non caseating granuloma  then we should
suspect tuberculosis16,17.  In  our  series,  endoscopy  showed  a
ulcerovegetative lesion 13 patients (41.9%)  distributed in the Upper Third
(n=6) and middle third esophagus (n=7). Extrinsic compression was noted
in 10 patients (n=10, 32.2%) most commonly in the middle third due to
mediastinal lymphadenopathy (n=6).
Barium  esophagogram showed extrinsic compression, traction
diverticula, stricture, sinus/fistulous tracts and kinking .
TEF was identified in 8 patients in our series. Of the four imaging
studies used to demonstrate a Tracheoesophageal fistula (Barium,
Endoscopy , CECT, Bronschoscopy ) ,the fistula was demonstrated in
1. six out of 8 patients in barium Esophagogram
2. five out of 8 patients in bronchoscopy
3. four out of 8 patients in Upper GI endoscopy
4. four out of 8 patients on CECT Chest/Neck
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In  our  review  of  literature,  barium  esophagogram  can  define  the
fistula  even  if  it  is  small  in  size.   TEF  can  also  be  demonstrated  by
bronchoscopy by identifying the methylene blue dye coming out through
the fistulous opening which is injected in the esophagus 18. Endoscopy can
overlook the fistulous opening in the esophagus due to the presence of
folds.
The most common finding on CECT chest/neck was enlarged
lymohadenopathy with or without suppuration in 11 patients (35.5%). In
addition CECT can demonstrate a fistula, esophageal thickening and
narrowing. However CECT was normal in 10 patients (32.2%).
There is no specific characteristic features of esophageal
tuberculosis in endoscopy ,chest Xray ,bronchoscopy or CT chest. The
lesions may mimic esophageal carcinoma,therefore we should consider
tuberculosis as a differential diagnosis in developing countries like India .
Histological proof is necessary to prove extrapulmonary tuberculosis
before starting medical therapy . Patients in our series,  diagnosis was
confirmed  most commonly by Endoscopic biospsy (n=14, 45.2% ) and CT
guided Biopsies (n=10, 25.8%) . The presence of epitheloid cell granuloma
with surrounding langhans giant cells with or without caseation was
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diagnostic of tuberculosis. Acid fast bacilli could be demonstrated in only
four patients (0.13%).
MANGEMENT
Although  Literature review shows that Tuberculous TEF can be
managed by medical therapy alone 19,20 ,in  our series, Surgery was
required  in  5  out  of  8  patients  with  TEF,  while  3  patients  were  managed
with  temporary stenting. The extended duration of medical therapy
required for healing tuberculous lesions and the acute morbidity and risk of
mortality caused by a TEF may necessitate surgical intervention when
esophageal tuberculosis is complicated by TEF.
Surgical Management includes  simple division and closure of the
fistula  or tracheal resection and reconstruction.20 All our cases were
managed by fistulous tract resection and closing the esophageal and the
tracheal opening separately with absorbable suture material (polyglactin ).
A Vascularized flap is kept in-between the suture lines using intercostal
muscle or a thick pleural flap. 20 A stent can also be used as a temporizing
measure when comorbidity precludes surgical therapy – as demonstrated in
3 patients in our series (9.7%). Nodal suppuration may require drainage to
relieve the dysphagia. (n=5, 16.12%)
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With standard antituberculous treatment patients showed excellent
response with complete healing of the lesions (n=31, 96.7%) . No deaths
have been recorded in the follow up. The relief of dysphagia was 100%
and there was no recurrence of the fistula.
 Conclusion
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CONCLUSION
This study shows that esophageal involvement is not isolated in
most patients. Dysphagia due to tuberculosis can be due to ulcerative
lesions or extraluminal compression due to lymphadenopathy.
Certain endoscopic features, such as deep and large vegetative
esophageal ulcers, tracheoesophageal fistula, and nonhealing ulcers, are
suggestive of tuberculous esophageal lesions and can morphologically
resemble malignant lesions.
Barium study has a greater sensitivity  to demonstrate the TEF in
our patients.
Diagnosis by histopathological evidence of granuloma with or
without caseous necrosis is reliable in endemic areas because lesions have
very low yield for AFB.
Although antituberculous therapy is the mainstay of treatment,
surgical intervention is the rule in those with serious complications.
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Appendix
Name Age/Sex
Presenting Complaints
Pressure Symptoms:
Pain
Satiety/vomiting
Breathlessness
 Pedal edema
Cough
Dyaphgia
Chest pain
Hemopstyisis
Wheeze
Odynophagia
Hoarseness of voice
Incidental finding upon evaluation for other causes
PAST HISTORY:
Tuberculosis
Drug intake
Medical illness
Physical findings:
Anaemia
Lymphadenopathy Chest signs
Investigation
Hb
Platelet count
Bilirubin
Imaging
•  Chest skiagram
•  Barium Swallow
• Esophagoscopy with Endoscopic ultrasound
• Fiberoptic Bronchoscopy
• CT Chest
Management
Surgery
Stent:
Medical Therapy

INFORMED CONSENT FORM
Title of the study -“ Management of Esophageal Tuberculosis : A Single Center
  Experience”
Name of the participant: ____________________________________________
Name of the Principal/Co-Investigator: _________________________________
Name of the Institution: Department of surgical gastroenterology, Madras Medical College and Rajiv
Gandhi government general hospital, Chennai
I,________(name of participant), have read the information in this form (or it has been read to me). I was
Free to ask any questions and they have been answered. I am over 18 years of age and, exercising
my  free power of choice, hereby give my consent to be included as a participant in ___ ” (title of the
study)
(1) I have read and understood this consent form and the information provided to me.
(2) I have had the consent document explained to me.
(3) I have been explained about the nature of the study.
(4)  I have been explained about my rights and responsibilities by the investigator.
(5) I have informed the investigator of all the treatments I am taking or have taken in the past
        ______ months including any native (alternative) treatments.
(6) I have been advised about the risks associated with my participation in the study.
(7) I agree to cooperate with the investigator and I will inform him/her immediately if I suffer unusual
      symptoms.
(8) I have not participated in any research study within the past _____ month(s).
(9) [I have not donated blood within the past _____months
(10) I am aware of the fact that I can opt out of the study at any time without having to give any
        reason and this will not affect my future treatment in the hospital
(11) I am also aware that the investigators may terminate my participation in the study at any
         time, for any reason, without my consent.
(12) I hereby give permission to the investigators to release the information obtained from me as
       result of participation in this study to the sponsors, regulatory authorities, Government agencies,
        and ethics committee. I understand that they may inspect my original records.
(13) I understand that my identity will be kept confidential if my data are publicly presented.
(14) I have had my questions answered to my satisfaction.
(15) I consent voluntarily to participate as a participant in the research study.
        I am aware, that if I have any questions during this study, I should contact the investigators. By
        signing this consent from, I attest that the information given in this document has been clearly
       explained to me and understood by me. I will be given a copy of this consent document.
For adult participants
Name and signature / thumb impression of the participant (or legal representative if participant
incompetent):
(Name) __________________________(Signature)___________________ Date: __________
Name and signature of impartial witness (required for illiterate patients):
(Name) __________________________ (Signature)___________________ Date:__________
Address and contact number of the impartial witness: _________________________________
Name and signature of the Investigator or his representative obtaining consent:
(Name) __________________________ (Signature)___________________ (Date)__________
For children being enrolled in research
Whether child’s assent was asked: Yes/ No
[If the answer to the above question is Yes, write the following phrase:
You agree with the manner in which assent was asked for from your child and given by your child.
You agree to have your child take part in this study.]
[If answer to the above question is No, give reason(s):___________________________
Although your child did not or could not give his or her assent, you agree to your child’s
participation in this study.]
Name and signature / thumb impression of the participant’s parent(s) (or legal representative):
(Name) __________________________ (Signature)______________ Date: __________
(Name) __________________________ (Signature)______________ Date: __________
Name and signature of impartial witness (required if parents of participant child illiterate):
(Name) __________________________ (Signature)______________ Date:__________
Address and contact number of the impartial witness: ___________________
______________________________________________
Name and signature of the Investigator or his representative obtaining consent:
(Name) __________________________ (Signature)_________________ (Date)__________
AGE SEX MAIN PRESENTATIONS ENDOSCOPY X RAY CHEST ESOPHAGOGRAM
1 28 M dysphagia/cough/wt loss/fever. TEF opening seen normal demonstrating fistula
2 41 M dysphagia with fever Normal normal normal
3 30 M dyaphagia/cough/wt loss/fever TEF opening seen rt basal pneumonitis narrowing with middle third fistula
4 37 F dysphagia with feverwith cough Normal normal normal
5 64 F dysphagia with cough Luminal narrowing /20 cm24cm bil/basal /pneumonitis fistula demonstrated
6 57 M dysphagia with cough Normal normal fistula demonstrated
7 41 F dysphagia with cough nodular lesion 20 cm/opening normal fistula demonstrated
8 56 M dysphagia ulerative growth 27 cm normal normal
9 46 M dysphagia/ wt loss/fever ulcerative lesion 25cm normal normal
10 51 F dysphagia/wt loss/fever normal normal normal
11 40 M dysphagia ulcerative lesion 25cmlesion 28 normal normal
12 36 M dysphagia normal normal mid esopgeal ulceration/luminal narrow
13 47 F dysphagia ulcerative lesion 17cm normal narrowing
14 27 F dysphagia/wt loss/fever ulcerative lesion 25cm apical lobe scar narrowing
15 28 M dysphagia ulcerative lesion 28 cm normal normal
16 45 M dysphagia/wt loss/fever ulcerative lesion 17cm normal normal
17 60 F dysphagia ulcerative lesion 18cm/narrowing normal narrowing upper third esophagus
18 63 M dysphagia ulcerative lesion 28/narrowing bil/lower lobe infiltraes normal
19 61 M dysphagia hoarhoarsness ulcerative lesion 17cm/narrowing normal normal
20 69 F dysphagia ulcerative lesion 18cm/narrowing normal normal
21 54 M dyphagia TEF opening seen /Ulceration 24 cm normal fistula demonstrated
22 39 M dysphagia/odynophagia normal enalrged neck nodes luminal narrowing cervical esophagus
23 28 F dysphagia luminal narrowing/18cm enalrged neck nodes ? Growth /irregularity/cervical esophagus
24 40 M dysphagia/wt loss/fever normal normal luminal narrowing middle third esophagus
25 48 F dysphagia extrinsic compression middle third loss of paratracheal stripe extrinsic compression middle third
26 50 M dysphagia extrinsic compression lower third loss of paratracheal stripe normal
27 61 M dysphagia extrinsic compression middle third loss of paratracheal stripe extrinsic compression middle third
28 62 F dysphagia/wt loss/fever extrinsic compression middle third normal normal
29 58 F dysphagia /fever extrinsic compression middle third loss of paratracheal stripe extrinsic compression middle third
30 59 M dysphagia /fever extrinsic compression middle third loss of paratracheal stripe extrinsic compression middle third
31 65 M dysphagia /fever extrinsic compression lower third normal normal
MASTER CHART
EUS HISOPATHOLOGY BRONCHOSCOPY CECT CHEST PROCEDURE
granulomotous lesion TEF fistulous opening seen not done trans thoracic repair
granulomotous lesion TEF fistulous opening seen fistulous tract seen trans thoracic repair
granulomotous lesion TEF fistulous opening seen fistulous tract /lymhadenopathy trans thoracic repair
granulomotous lesion TEF fistulous opening seen fistulous tract /lymhadenopathy trans thoracic repair
granulomotous lesion TEF fistulous opening seen esophageal thickening stent
granulomotous lesion not done stent
granulomotous lesion esophageal thickening stent
granulomotous lesion normal medical therapy
granulomotous lesion ulcer demonstrated normal medical therapy
granulomotous lesion ulcer demonstrated esophageal thickening,lymphadenopathy medical therapy
granulomotous lesion normal medical therapy
granulomotous lesion esophageal thickening /narrowing medical therapy
granulomotous lesion normal normal medical therapy
granulomotous lesion esophageal thickening medical therapy
granulomotous lesion esophageal thickening medical therapy
granulomotous lesion normal medical therapy
AFB positive normal medical therapy
granulomotous lesion normal medical therapy
granulomotous lesion narrowing upper third medical therapy
granulomotous lesion narrowing upper third medical therapy
granulomotous lesion fistulous tract seen trans thoracic repair
AFB positive normal cervical node drainage
granulomotous lesion cervical lymphadenopathy cervical node drainage
granulomotous lesion noadal mass(2x3cm) paratracheal region medical therapy
nodal mass middle third/FNA AFB positive normal medical therapy
mediastinal lymphadenopathy AFB positive mass /extrinsic compression/middle third medical therapy
granulomotous lesion normal medical therapy
granulomotous lesion mediastinal mass middle third open drainage esophageal wall Bx
granulomotous lesion mass subcarinal 3.5 cm medical therapy
granulomotous lesion carina lifted up mass subcarinal 3.5 cm open drainage esophageal wall Bx
granulomotous lesion carina lifted up mass subcarinal 3.5 cm/cervical nodes open drainage esophageal wall Bx



